Cargando…
Correction: Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial
Autores principales: | Wise, Robert A., Holbrook, Janet T., Criner, Gerard, Sethi, Sanjay, Rayapudi, Sobharani, Sudini, Kuladeep R., Sugar, Elizabeth A., Burke, Alyce, Thimmulappa, Rajesh, Singh, Anju, Talalay, Paul, Fahey, Jed W., Berenson, Charles S., Jacobs, Michael R., Biswal, Shyam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370156/ https://www.ncbi.nlm.nih.gov/pubmed/28350841 http://dx.doi.org/10.1371/journal.pone.0175077 |
Ejemplares similares
-
Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial
por: Wise, Robert A., et al.
Publicado: (2016) -
Compartmentalization of anti-oxidant and anti-inflammatory gene expression in current and former smokers with COPD
por: Sidhaye, Venkataramana K., et al.
Publicado: (2019) -
Sulforaphane improves the bronchoprotective response in asthmatics through Nrf2-mediated gene pathways
por: Brown, Robert H., et al.
Publicado: (2015) -
Nrf2 regulates gene-environment interactions in an animal model of intrauterine inflammation: Implications for preterm birth and prematurity
por: Sussan, Thomas E., et al.
Publicado: (2017) -
Sulforaphane Bioavailability from Glucoraphanin-Rich Broccoli: Control by Active Endogenous Myrosinase
por: Fahey, Jed W., et al.
Publicado: (2015)